<DOC>
	<DOC>NCT02471261</DOC>
	<brief_summary>Elastography as Gouty Arthropathy Outcome (EGO), a pilot study.</brief_summary>
	<brief_title>Elastography as Gouty Arthropathy Outcome (EGO)</brief_title>
	<detailed_description>Pilot study to assess 10 subjects with tophaceous gout on urate lowering therapy or about to begin urate lowering therapy.</detailed_description>
	<mesh_term>Joint Diseases</mesh_term>
	<mesh_term>Arthritis, Gouty</mesh_term>
	<criteria>1. Subjects who are at least 18 years of age but younger than or equal to 99 years of age. 2. Subjects with gouty arthritis as determined by the ACR 1977 classification criteria for gouty arthritis. 3. Subjects with one palpable tophus detectable by one of the three clinical parameters described. 1. Subjects who are not eligible for urate lowering treatment or show a hypersensitivity to these drugs or class of compounds. 2. Subjects with significant cardiovascular, neuropsychiatric, hematologic, hepatic, renal or endocrine dysfunction who in the opinion of the principal investigator are unfit for participation in a clinical trial. 3. Subjects for which the clinical and laboratory assessment would provide undue discomfort and / or are contraindicated.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>